Clin2
NCT07691372Worth exploringNot yet recruiting

Single-dose ketamine wafer study in healthy adults

Healthy Adult Participants

This study tests a single dose of a ketamine wafer that dissolves under the tongue in healthy adults. It checks how the drug moves through the body and if it is safe. It may help people with certain conditions where ketamine is being explored as a treatment.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
14 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You must be between 18 and 65 years old.
  • You must be in good general health with no major medical problems.
  • You must have a body mass index (BMI) between 18.5 and 30.
  • You must not be pregnant or breastfeeding, and must agree to use effective contraception if needed.
  • You must not have used tobacco or nicotine products in the last 30 days.
  • You must not have a history of drug or alcohol abuse.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05401227Recruiting· Phase 1
Brain scan study on glutamate and ketamine in healthy adults

This study uses a special brain scan (MRI) to understand how the brain chemical glutamate works in healthy people. You may be asked to take either an experimental drug or a placebo to see how it affects your brain chemistry.

New York, New York
NCT07683988Not yet recruiting· Phase 1
Ketamine for treatment-resistant depression

This trial tests if ketamine (taken as a pill or under the tongue) can help people with moderate to severe depression that hasn't improved with at least two other antidepressants. The goal is to find out if this approach is safe and effective.

NCT06788249Recruiting· Early Phase 1
Ketamine for treatment-resistant depression brain study

This trial tests whether a single dose of ketamine can quickly improve depression by studying brain chemical changes using MRI. It's for people with treatment-resistant depression who haven't used ketamine before.

Philadelphia, Pennsylvania
NCT07504601Not yet recruiting· Phase 2
Testing a ketamine-related drug for short-term pain in healthy adults

This study tests whether a new drug called (2R,6R)-HNK can reduce pain caused by heat in healthy volunteers. The results will help researchers understand if this drug might be useful for treating acute (short-lasting) pain in the future.

Bethesda, Maryland
NCT04861051Recruiting· Phase 1
Study ketamine effects on brain sensations in adults

This Phase 1 study tests how ketamine changes “dissociative” experiences—feelings of being disconnected from thoughts or surroundings—in adults. You may be helping researchers better understand ketamine’s effects, which could guide safer future uses.

Palo Alto, California
NCT05327699Recruiting· Early Phase 1
Ketamine study for depression with reduced pleasure

This early-phase study tests whether ketamine can help people with major depression who have trouble feeling pleasure. It also studies how the brain may change in response to stress, to better understand who might respond to treatment.

Atlanta, Georgia

Hear when a new Healthy Adult Participants trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.